Brought to you by:
Coding workshop to cover 2025 updates
Registration for the annual Society for Vascular Surgery (SVS) Coding and Reimbursement Workshop—and optional evaluation and management (E/M) coding workshop—opened July 9 with early-bird registration available until Aug. 6. This 1.5-day intensive program, scheduled for Nov. 3–4 in Rosemont, Illinois,…
Medtronic to distribute FMD’s peripheral guidewires for transradial access in US
Medtronic today announced it has entered into an exclusive U.S. distribution agreement with Japan-based Future Medical Design Co (FMD) to sell specialty and workhorse peripheral guidewires. This agreement includes the first 400cm, 0.018″ peripheral guidewire available in the U.S., expanding…
Novel MRI technique for CLTI poised to address ‘medieval problem in modern medicine’
“We want to change global standards. What we’re doing isn’t working. Patients are getting hurt and devices are failing—we want to be able to make sure devices we’re using today are safe, so that we can build new devices that…
International Chapter highlights pressing need to document PAD and CLTI prevalence in South Asia
There is an urgent need for epidemiological studies to map out the prevalence of chronic limb-threatening ischemia (CLTI)—and peripheral arterial disease (PAD) in general—in South Asia, attendees of the International Chapter Education Session at VAM 2025 heard yesterday morning. That…
Transcatheter arterialization of the deep veins: Comparative analysis probes whether emerging modality is worth pursuing
“We’re living in a new world order” when it comes to “no-option” chronic limb-threatening ischemia (CLTI) patients, says Anahita Dua, MD. In recent years, into this arena has stepped transcatheter arterialization of the deep veins (TADV), raising hopes of reducing…
First-in-man results to show promise for robot-assisted HIFU in PAD treatment
Results of a first-in-human study of non-invasive, robotic-assisted high intensity focused ultrasound (HIFU) for the treatment of peripheral arterial disease (PAD), to be presented Friday morning, will show that the therapy appears to be safe and feasible for the treatment…
What the cost of cancer care teaches vascular specialists
How does the cost of treating critical limb-threatening ischemia (CLTI) in the U.S. stack up to cancer care? That was the question at the heart of research conducted by Richard W. Walsh, MD, and colleagues at the University of Texas…
Cost-effectiveness outcomes defy expectations in latest BEST-CLI data drop
The open surgical approach will prove to be “slightly superior” to endovascular intervention in terms of cost per life year gained, while the latter will be slightly superior to open surgery with regard to cost per quality-adjusted life year gained,…
SVS releases updated guidelines for intermittent claudication
The Society for Vascular Surgery (SVS) has issued a comprehensive update to its clinical practice guidelines for the management of intermittent claudication, urging clinicians to prioritize conservative treatment strategies and patient-centered care. The new guidelines, published in April 2025, reflect…
Equivalent outcomes seen among female, male patients in real-world analysis of paclitaxel-eluting stent use
The use of a paclitaxel-eluting stent to treat femoropopliteal occlusive disease led to equivalent outcomes in male and female patients in “a diverse and complex real-world cohort,” a new study found, set against previous question marks over the effectiveness of…